Development and validation of direct assay for cholesterol content of erythrocytes
Open Access
- 17 July 2025
- journal article
- metabolism
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 45 (07) , 415-427
Abstract
Erythrocytes contain a significant amount of membrane cholesterol, which is continuously exchanged with lipoproteins. Recent studies suggest that erythrocyte cholesterol content correlates positively with atherosclerotic cardiovascular disease (ASCVD) severity independent of low-density lipoprotein levels, potentially reflecting residual ASCVD risk. However, conventional methods for measuring erythrocyte cholesterol content require labor-intensive lipid extraction procedures, limiting their clinical applicability. In this study, we developed a novel enzymatic assay that enables direct quantification of erythrocyte total cholesterol content using two denaturants to eliminate hemoglobin interference. This simple method demonstrated high accuracy and precision, as confirmed by intra-assay repeatability, between-day precision, linearity, and spike-recovery tests. Using this assay, we determined the erythrocyte cholesterol content per volume (154.8 ± 2.9 mg/dl in men, 155.9 ± 6.9 mg/dl in women) and per cell (139.0 ± 5.2 fg/cell in men, 140.8 ± 5.3 fg/cell in women) (n = 12, healthy subjects). While erythrocyte cholesterol content per volume correlated with the conventional method, the erythrocyte cholesterol content per cell showed no such correlation. Moreover, neither measure was associated with serum lipid levels, suggesting their potential as independent biomarkers for ASCVD. Additionally, we evaluated erythrocyte cholesterol content across different maturation stages and found that older erythrocytes had significantly lower cholesterol content, consistent with mass spectrometry results. These findings further validated the physiological relevance of the proposed method. In conclusion, we successfully established a simple and clinically applicable enzymatic method for measuring erythrocyte cholesterol content, providing novel insights into erythrocyte cholesterol metabolism and its potential role in ASCVD risk assessment.Keywords
Funding Information
- Japan Society for the Promotion of Science (22K07466, 23H05349, 24H02699)
- Hitachi Global Foundation (None)
This publication has 31 references indexed in Scilit:
- Detection of methemoglobin in whole blood based on confocal micro‐raman spectroscopy and multivariate statistical techniquesScanning, 2014
- Total cholesterol content of erythrocyte membranes levels are associated with the presence of acute coronary syndrome and high sensitivity C-reactive proteinInternational Journal of Cardiology, 2010
- Dietary lipid intake influences the level of cholesterol bound to haemoglobin in human erythrocytesEuropean Journal of Nutrition, 2008
- Total Cholesterol Content of Erythrocyte Membranes Is Increased in Patients With Acute Coronary SyndromeJACC, 2007
- Cholesterol bound to hemoglobin in normal human erythrocytes: a new form of cholesterol in circulation?Clinical Biochemistry, 2004
- Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age, and clearance by mononuclear cells.Journal of Biological Chemistry, 1994
- Effects of membrane lipid composition on the kinetics of cholesterol exchange between lipoproteins and different species of red blood cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1990
- Cholesterol and the cell membraneBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1985
- New method for hemoglobin determination by using sodium lauryl sulfate (SLS)Clinical Biochemistry, 1982
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977